Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 191 in Vertex

  1. Obama talks up research, announces personalised medicine initiativeRead the original story w/Photo

    Friday Jan 23 | Chemistry World

    ... budget. In announcing the new programme, Obama indirectly referenced a therapy by Boston-based biotechnology company Vertex Pharmaceuticals that targets patients that have cystic fibrosis linked to a specific gene deletion. Ben Corb , a spokesperson ...

    Comment?

  2. Shed the Weight! Developing Standard Operating Procedures According to Lean PrinciplesRead the original story

    Thursday Jan 22 | Pharmaceutical Online

    ... advantage of EDC technology. Prior to joining Halloran, Denise was Director of Clinical Planning and Performance at Vertex Pharmaceuticals, where her group coordinated planning activities, process development, and performance metrics among the ...

    Comment?

  3. State of the Union Address Investing Idea: Precision MedicineRead the original story w/Photo

    Wednesday Jan 21 | The Motley Fool

    ... fibrosis patient, to sit with the first lady during the address. The drug Elder takes wasn't mentioned by name, but Vertex Pharmaceuticals ' ( ) Kalydeco is the logical conclusion, since it's the only drug approved drug to treat the underlying ...

    Comment?

  4. The BBJ's Five Things: Vertex's big moment; Nurses unite; Top home sales; Alnylum cashes inRead the original story w/Photo

    Wednesday Jan 21 | Business Journal

    Good morning, Boston! Here are the five most important things you need to know to help start your busy business day: No one exactly knew what President Barack Obama would highlight in his State of the Union address last night. But given that one of the guests sitting with the First Lady was a cystic fibrosis patient taking a drug for that disease, chances were high that Vertex Pharmaceuticals and its role in the field of precision medicine would come up.

    Comment?

  5. Obama might mention Vertex in tonight's State of the UnionRead the original story w/Photo

    Tuesday Jan 20 | Business Journal

    No one exactly knows what President Barack Obama will highlight in his State of the Union address tonight, but given that one of the guests to sit with the First Lady's will be a cystic fibrosis patient taking a drug for that disease, chances are that Vertex Pharmaceuticals and its role in the field of precision medicine may well come up.

    Comment?

  6. With $450M sale, Alnylam has more cash than any pre-commercial biotechRead the original story w/Photo

    Tuesday Jan 20 | Business Journal

    ... largest amount of cash among Massachusetts-based biotechs, exceeding only by Biogen Idec (which has $3.2 billion) and Vertex Pharmaceuticals (which has $1.5 billion). Both of those companies, however, have approved drugs which bring in revenue: ...

    Comment?

  7. The Fallon Company Continues Fan Pier Momentum As It Celebrates Topping Off of 100 Northern AvenueRead the original story

    Friday Jan 16 | Business Wire

    ... space will be occupied by Global 100 Law Firm Goodwin Procter LLP , who will join leading companies such as Vertex Pharmaceuticals , Battery Ventures , Polaris Partners Fish & Richardson , and EnerNOC in moving to Fan Pier. A LEED Silver ...

    Comment?

  8. Vertex Pharmaceuticals Going to Get Fat on Cystic Fibrosis PieRead the original story w/Photo

    Friday Jan 16 | The Motley Fool

    ... the gate open, allowing salts to pass through, reducing mucus buildup, and increasing patients' ability to breathe. Vertex believes it can achieve Kalydeco sales of between $560 million and $580 million this year. That's up substantially from ...

    Comment?

  9. Unum Therapeutics Expands Management Team with Appointment of...Read the original story

    Monday Jan 12 | Freshnews

    ... Most recently, Ms. Stamoulis was the Senior Vice President and Head of Corporate Strategy and Business Development at Vertex Pharmaceuticals, where she helped develop the company's vision and led its efforts to form strategic business ...

    Comment?

  10. 3 Ways Gilead Sciences, Inc. Could Still Be in Big TroubleRead the original story w/Photo

    Sunday Jan 11 | The Motley Fool

    ... levels of HCV, and it had many unpleasant side effects, including rashes and flu-like symptoms. Then in 2011, Vertex Pharmaceuticals introduced Incivek , a pill that eliminated detectable levels of HCV in nearly 80% of patients, but it still had to ...

    Comment?

  11. Tokyo Auto Salon 2015 - Day Two Photo GalleryRead the original story w/Photo

    Dec 3, 2014 | Super Street

    ... car platforms, but here they still embrace cars from the 90s, 80s, and even the 70s. Hell, Takahiro Ueno and his Vertex crew made a Toyota Prius look and sound really really cool. I found myself outside with the Hardcore Japan crew and Formula D ...

    Comment?

  12. Software, hardware short takesRead the original story

    Wednesday Dec 31 | Oil IT Journal

    Baker Hughes, PetroDE, Aveva, BPT, Geosoft, HP/Autonomy, Madagascar, MCAConnect, Mentor Labs, Schlumberger, Pegasus Vertex, Recon Technology, CGG/Hampson-Russell, Rock Flow Dynamics, Stone Bond, Yokogawa. .... ... This article contains approximately 485 words This article contains approximately 485 words.

    Comment?

  13. Vertex Pharmaceuticals Research Coverage Started at BarclaysRead the original story

    Tuesday Jan 6 | AmericanBankingNews.com

    ... the subject of a number of other recent research reports. Analysts at BTIG Research initiated coverage on shares of Vertex Pharmaceuticals in a research note on Tuesday. They set a "buy" rating and a $200.00 price target on the stock. Separately, ...

    Comment?

  14. J.P. Morgan Chimes In With Ratings On BioTech StocksRead the original story

    Tuesday Jan 6 | GuruFocus.com

    J.P. Morgan analyst Cory Kasimov rated a slew of bio-technology stocks on January 5, including Vertex Pharmaceuticals , Regeneron , Gilead Sciences , Celgene Corporation , Biogen Idec , and Acorda Therapeutics . Kasimov's ratings are mostly Bullish, however he has a few reservations about some stocks.

    Comment?

  15. Biotech band has good chemistry www.utsandiego.com...Read the original story w/Photo

    Monday Jan 5 | The San Diego Union-Tribune

    Six chemists and engineers from Vertex biotech in La Jolla have joined to form The Halides. On Jan. 10, 2015 they are releasing their first CD with profits going toward cystic fibrosis.

    Comment?

  16. Vertex Pharmaceuticals PT Set at $130.00 by JPMorgan Chase & Co.Read the original story

    Monday Jan 5 | AmericanBankingNews.com

    ... analysts have also recently weighed in on VRTX. Analysts at RBC Capital reiterated a "positive" rating on shares of Vertex Pharmaceuticals in a research note on Tuesday, December 30th. Separately, analysts at Zacks reiterated a "neutral" rating on ...

    Comment?

  17. 10 big stories in the life science industry to watch in 2015Read the original story w/Photo

    Friday Jan 2 | Business Journal

    ... as it stands. Given its success to date, he'd have a tough time arguing it hasn't been effective. 2: The launch of Vertex Pharmaceuticals' biggest drug yet : The Boston-based drug firm's gamble on its drugs for cystic fibrosis paid off last year, ...

    Comment?

  18. US open: Markets rise after holiday breakRead the original story

    Friday Jan 2 | Live Charts

    ... on a benchmark US 10-year Treasury was retreating by six basis points to 2.12%. Meanwhile, in the corporate world Vertex Pharmaceuticals was rising 3.4% while Danbury Resources was plummeting 5.31%. Stock News is provided by Digital Look Corporate ...

    Comment?

  19. Nasdaq 100 Movers: TSLA, VRTXRead the original story w/Photo

    Friday Jan 2 | Forbes.com

    ... to our MarketNewsVideo.com website and through our distribution partners. In early trading on Friday, shares of Vertex Pharmaceuticals (VRTX) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.1%. Year to ...

    Comment?

  20. S&P 500 Movers: DNR, VRTXRead the original story w/Photo

    Friday Jan 2 | Forbes.com

    ... to our MarketNewsVideo.com website and through our distribution partners. In early trading on Friday, shares of Vertex Pharmaceuticals (VRTX) topped the list of the day's best performing components of the S&P 500 index, trading up 3.4%. Year to ...

    Comment?